Mondelez

MDLZ rose to 63.36 USD in pre-market trading (08:19 ET) but faced persistent selling pressure thereafter, declining to 62.005 USD (14:21 ET) during regular hours before a modest post-market recovery to 62.56 USD, ending the day down approximately 0.65% versus the prior close. The intraday decline reflects profit-taking following last week's 5.79% gain that outpaced the S&P 500. Q2 earnings showed EPS of 1.20 USD surging 144.9% year-over-year with net margins at 16.55%, yet revenue growth lagged at just 4.13%, creating a divergence between profit and sales expansion that raises valuation concerns. Analyst opinions remain mixed, with Bernstein maintaining a Buy rating while JPMorgan issued a bearish outlook. The stock trades at a P/E of 22.63, below its 52-week high of 66.65 USD by 6.45%, though up 16.22% year-to-date.

MDLZ fell 2.1% to $63.39 in trading after last week's 5.79% rally, as profit-taking and divergent analyst views weighed—JPMorgan bearish, Bernstein bullish. Q2 results impressed: EPS of $1.20 (+144.9% YoY), net income up 141.5%, though revenue grew 4.13%. Stock is up 18.92% YTD and trades 4.28% below $66.65 52-week high, above $61.91 60-day average. Cocoa hedging and new Ritz product support the thesis, though 23.16 PE reflects elevated expectations.

Mondelez surged approximately 4.3% to close at $65.19, extending to $65.45 in post-market trading, driven primarily by robust second-quarter earnings and new product launches. Q2 earnings per share reached $1.20 with YoY growth of 144.9%, while net profit jumped $1.548B, up 141.5% year-over-year, and operating profit surged 70.62%, demonstrating significant profitability acceleration that captured market interest. Support also came from the introduction of new Ritz varieties that consumers have sought after, favorable cocoa grinding data, and Buy ratings from analysts including Bernstein. The stock now trades just 2.19% below its 52-week high of $66.65, having gained 21.51% year-to-date, and sits notably above both the 20-day and 60-day moving averages at $61.01 and $61.90 respectively. The company carries a PE of 23.66 and a dividend yield of 3.10%. However, JPMorgan recently issued a pessimistic forecast and UBS maintains a Hold rating, suggesting divergence in market views regarding near-term growth prospects.

Mondelez retreated roughly 2% to $62.74 as profit-taking pressures intensified following last week's strong +5.79% gain, compounded by underperformance versus competitors. The stock rallied to $64.27 in pre-market trading before encountering selling throughout the session, with intraday lows reaching $62.38. Q2 earnings proved robust, with EPS climbing to $1.20 (up 144.9% year-over-year), revenues totaling $93.55 billion (+4.13% YoY), and net profit surging 141.5% to $15.48 billion. The stock continues to trade above its 20- and 60-day moving averages and is up 16.94% year-to-date, though it remains 5.87% below its 52-week high of $66.65. Analyst sentiment shows divergence: Bernstein maintains Buy, UBS has assigned Hold, and JPMorgan recently turned negative. On valuation, the stock carries a PE multiple of 22.77x and PB of 3.01x, positioning it at relatively elevated levels.

MDLZ edged up 1% today, though it retreated from the pre-market high of $64.06 (09:29 ET), closing at $63.99, suggesting profit-taking pressure. Q2 earnings delivered a powerful catalyst: EPS surged 145% year-over-year to $1.20, with net income jumping 142% to $1.548 billion, while net profit margin expanded to 16.55% from Q1's 5.56%, underlining strong cost control and pricing power. On commodities, the company's cocoa cost cushion remains intact as El Niño risks fade. Product-wise, Mondelez unveiled a new Ritz variety responding to long-standing consumer demand. Year-to-date the stock has risen 19.27%, now trading 3.99% below the 52-week high of $66.65, well above its 20-day and 60-day moving averages. That said, JPMorgan recently cautioned on the company's stock price outlook, reflecting lingering valuation debates among investors.